Cancer Cell | November 14, 2016 Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia Mutations in SF3B1, which encodes a spliceosome component, are associated with poor outcome in chronic lymphocytic leukemia (CLL), but how… Read More
November 7, 2016 H3 Biomedicine to Present New Data from Lead Development Program at 2016 American Society of Hematology Annual Meeting Oral Presentation to Demonstrate H3B-8800’s Potential on Spliceosome Mutant Cells in Hematological Cancers Read More